Altre lingue Krebs Biochemicals & Industries Limited NSE India S.E.

Azioni

KREBSBIO

INE268B01013

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:40:30 16/07/2024			Variaz. 5gg	Var. 1 gen.
85,07 ^INR	+1,75%		+0,82%	+8,58%

21/05	Krebs Biochemicals & Industries Limited nomina Rakesh Kalbate come Segretario aziendale/Funzionario di conformità	CI
21/05	Krebs Biochemicals & Industries Limited riporta i risultati degli utili per il quarto trimestre e l'intero anno terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	21/05
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	21/05
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	15/04
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer	17/01
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant	18/12
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer	20/10/23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09/08/23
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director	09/08/23
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023	09/08/23
Krebs Biochemicals Trims Net Loss in Fiscal Q4	24/05/23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	24/05/23
Krebs Biochemicals Names New CFO	03/02/23
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer	03/02/23
Krebs Biochemicals & Industries Limited Approves CFO Changes	03/02/23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt	06/09/22
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	01/08/22
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022	01/08/22
Krebs Biochemicals & Industries : Financial Result Updates	23/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Krebs Biochemicals & Industries Limited NSE India S.E.

Azioni

KREBSBIO

INE268B01013

Altre lingue

Filtri